A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
Clinical trial NCT01458535 · COMPLETED
Trial details
- NCT number
- NCT01458535
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-05-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.